INFORMATION FOR
News
The Global Virus Network (GVN), comprising eminent human and animal virologists from more than 80 centers of excellence and affiliates in over 40 countries, announced the addition of Yale University as one of four new GVN Centers of Excellence. Researchers from Yale School of Public Health and Yale School of Medicine will serve as the center's co-leaders
Inci B. Yildirim, M.D., Ph. D, M.Sc, has been named section chief of pediatric infectious diseases & global health at Yale School of Medicine, effective August 1, 2024.
Researchers with Mount Sinai Hospital and Yale University say they’re the first to identify specific blood biomarkers that can accurately identify long Covid—allowing them to create an algorithm to determine whether a patient is suffering from the lingering condition, according to a new study published Monday in the journal Nature.
The Yale School of Medicine’s new Center for Infection & Immunity, which launched on Aug. 18, is researching post-acute infection syndromes while encouraging diversity, elevating scientists and incorporating patients as research partners.
The Yale Pediatric Vaccine Trials Program played a significant role in another vaccine licensure.
Several members of our faculty in the department of Pediatrics received awards for their distinguished service in teaching for the 2022-2023 academic year.
Doctors Marietta Vázquez and Inci Yildirim, specialists in pediatrics and infectious diseases respectively, will participate in the annual meeting
Scientists have identified the immune signature of rare cases of myocarditis among those vaccinated against COVID-19 with mRNA vaccines.
A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine.
Researchers observed elevated levels of immune molecules that, in rare cases, could trigger inflammation in the heart.
Yale researchers have received a $12 million award from the NIH as part of the Human Immune Project Consortium to study vaccine responses in vulnerable groups, including patients with multiple sclerosis (MS) undergoing B cell depletion therapy, older adults including particularly vulnerable older residents of long-term care facilities, and certain individuals with sickle cell disease.
Vaccination of children to prevent coronavirus disease 2019 (Covid-19) is an urgent public health need. The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children 6 to 11 years of age are unknown.
These medicines can protect people at high risk for severe illness from COVID-19.
The Adult and Pediatric Transplant Infectious Diseases teams are hosting a new educational conference series for the 2021-2022 academic year.
Two of the commonly used coronavirus vaccines provide protection against multiple variants of the virus that causes COVID-19, including the highly infectious Delta variant, a new Yale study has found.
COVID-19 vaccine uptake among US child care providers was higher than the general US adult population.
COVAX reported roughly a quarter reduction in their vaccine supply forecast for the remainder of 2021. The World Health Organization is asking countries to delay administering boosters until the end of the year. Experts say this delay would help ramp up vaccine production and make more vaccines available for lower-and middle-income countries.
Connecticut is making preparations to offer Covid-19 booster shots for those 65 and older or those identified as high risk who previously received a Pfizer vaccine, the state Department of Public Health said Friday.
Doctors say they are noting more instances of children falling severely ill as the pandemic has progressed and the delta variant has become predominant.
The good, the bad and the unresolved on COVID-19 vaccinations.